Similar articles

• Oxiracetam prevents the hippocampal cholinergic hypofunction induced by the NMDA receptor blocker AP7.

  Belfiore P, Ponzio F, Biagetti R, Berettera C, Magnani M, Pozzi O. Belfiore P, et al. Neurosci Lett. 1992 Aug 31;143(1-2):127-30. doi: 10.1016/0304-3940(92)90248-6. Neurosci Lett. 1992. PMID: 1436656
• Homocysteic acid as a putative excitatory amino acid neurotransmitter: I. Postsynaptic characteristics at N-methyl-D-aspartate-type receptors on striatal cholinergic interneurons.

  Lehmann J, Tsai C, Wood PL. Lehmann J, et al. J Neurochem. 1988 Dec;51(6):1765-70. doi: 10.1111/j.1471-4159.1988.tb01157.x. J Neurochem. 1988. PMID: 2846784
• Oxiracetam and D-pyroglutamic acid antagonize a disruption of passive avoidance behaviour induced by the N-methyl-D-aspartate receptor antagonist 2-amino-5-phosphonovalerate.

  Paoli F, Spignoli G, Pepeu G. Paoli F, et al. Psychopharmacology (Berl). 1990;100(1):130-1. doi: 10.1007/BF02245803. Psychopharmacology (Berl). 1990. PMID: 2153307
• The specific NMDA receptor antagonist AP-7 attenuates focal ischemic brain injury.

  Roman R, Bartkowski H, Simon R. Roman R, et al. Neurosci Lett. 1989 Sep 25;104(1-2):19-24. doi: 10.1016/0304-3940(89)90322-4. Neurosci Lett. 1989. PMID: 2554220
• Involvement of NMDA receptors in non-convulsive epilepsy in WAG/Rij rats.

  Peeters BW, van Rijn CM, Vossen JM, Coenen AM. Peeters BW, et al. Life Sci. 1990;47(6):523-9. doi: 10.1016/0024-3205(90)90612-u. Life Sci. 1990. PMID: 2169562